Skip to main content
. 2012 Jul 25;43(5):534–538. doi: 10.1007/s00595-012-0268-8

Table 1.

Patient and tumor characteristics, operative details and outcomes

Hepatitic status, n
 Hepatitis B Cartier 0
 Hepatitis C Cartier 0
Liver cirrhosis, n 0
Liver functional status, n
 Child-Pugh Grade A 30
 Child Pugh Grade B 0
Comorbidities, n
 Hypertension 13
 Ischemic heart disease 5
Preoperative laboratory tests
 Hemoglobin (g/dL) 13.1 ± 2.2
 Platelet count (106/mL) 194 ± 33
 Aspartate aminotransferases (U/L) 19.5 ± 3.5
 Alanine aminotransferases (U/L) 16.0 ± 5
 Bilirubin (md/dL) 0.84 ± 0.5
 Prothrombin time (s) 14.2 ± 0.8
 Albumin (g/L) 39.1 ± 13.2
 Creatinine(μmol/L) 59.2 ± 22
Indications for resection, n
 Hepatocellular carcinoma 9
 Metastases of colorectal cancer 13
 Hemangioma 5
 Hepatic adenoma 3
Tumor nodules, n 1
Tumor size (cm) 7.5 ± 5.2
Tumor volume (cm3) 110 ± 25
Types of liver resections, n
 Right hemihepatectomy 20
 Left hemihepatectomy 10
Operative time (min) 135 ± 45
Intraoperative blood loss (mL) 430 ± 140
Transfusion requirements
 Patients transfused, n 9
 Packets red cells (U) 2.6 ± 0.8
Patients with complications 4
Type of complication, n
 Hepatic insufficiency 0
 Hemorrhage 0
 Bile leak 0
 Atrial fibrillation 1
 Superficial wound infection 2
 Pulmonary thrombosis 1
 Reoperation 0
Postoperative hospital stay (days) 10.1 ± 3.1